← Eichor
Study identifier: NCT06662942 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

Condition: Vulvar Lichen Sclerosus  ·  Sponsor: Andrew T. Goldstein, MD

PhasePhase 1
Planned participants100
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

Andrew T Goldstein, MD  ·  4102790209  ·  obstetrics@yahoo.com

Sylvia Lorenzini  ·  sylvia@vulvodynia.com

Always discuss trial participation with your own doctor first.

Locations (3)

Centers for Vulvovaginal Disorders, DCWashington D.C., District of Columbia, United StatesRecruiting
Centers for Vulvovaginal Disorders, FLTampa, Florida, United StatesRecruiting
Centers for Vulvovaginal Disorders, NYNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06662942